Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Extracellular Vesicles (EV)-Exosomes: Diagnostics, Delivery and Therapeutics

Chris Baldwin's Biography

Chris Baldwin, Chief Commercial Officer, Exopharm Ltd.

Dr Chris Baldwin joined Exopharm in November 2019, bringing a wide range of global commercial experience to the company.

Chris’ strategic focus and approach to management comes from his time at McKinsey and Company, where he served banking, pharmaceutical and NGO clients.

More recently, Chris was responsible for Haemonetics’ largest and most profitable business unit across Asia Pacific, with P&L responsibilities from Taiwan to Pakistan. Previously responsible for all sales and marketing in Southeast Asia, Chris provided strategy leadership across Asia Pacific, including China.

Healthcare became the focus of Chris’ career at New York Blood Center, where he was Executive Director for 8 years and responsible for the blood supply across the greater New York metropolitan area.

Chris received his PhD in Chemical Engineering from the University of Cambridge, while matriculated at Trinity College.

Chris Baldwin Image

Designing Engineered EVs for Virus X

Thursday, 25 February 2021 at 15:30

Add to Calendar ▼2021-02-25 15:30:002021-02-25 16:30:00Europe/LondonDesigning Engineered EVs for Virus XExtracellular Vesicles (EV)-Exosomes: Diagnostics, Delivery and Therapeutics in Virtual ConferenceVirtual

Exopharm will report on its early work of conferring tropism to exosomes using SARS-CoV-2 spike protein to deliver siRNA to impede coronavirus replication and its implication for future pandemic responses.

Add to Calendar ▼2021-02-25 00:00:002021-02-26 00:00:00Europe/LondonExtracellular Vesicles (EV)-Exosomes: Diagnostics, Delivery and TherapeuticsExtracellular Vesicles (EV)-Exosomes: Diagnostics, Delivery and Therapeutics in Virtual ConferenceVirtual